Skip to content

Effect of Ursolic Acid of Loquat Extract on Function of Muscle

Effect of Ursolic Acid of Loquat Extract on Function of Muscle in Human

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02401113
Enrollment
54
Registered
2015-03-27
Start date
2014-11-30
Completion date
2015-10-31
Last updated
2015-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia

Brief summary

This randomized, placebo-controlled, double-blind study was designed to investigate the efficacy and tolerability of Ursolic Acid of Loquat Extract for treatment of muscle function improvement with relatively health adults. 54 subjects received 500 mg of Loquat Extract per day or a placebo for 12 weeks.

Detailed description

This randomized, placebo-controlled, double-blind study was designed to investigate the efficacy and tolerability of Ursolic Acid of Loquat Extract for treatment of muscle function improvement with relatively health adults. 54 subjects received 500 mg of Loquat Extract per day or a placebo for 12 weeks. Change over time in muscle fuction was evaluated by four outcomes: assessment of appendicular skeletal mass using DEXA (dual energy X-ray absorptiometry); quadriceps muscle power by Biodex; hand grib power; and Short Physical Performance Battery, SPPB.

Interventions

DIETARY_SUPPLEMENTUA group

Ursolic Acid of Loquat Extract, 500mg/ day during 12 weeks

Sponsors

Pusan National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI 18.5-30KG/M2

Exclusion criteria

* \> SERUM creatinine 1.2mg/dL * \> AST or ALT 60IU/L * DM Patients

Design outcomes

Primary

MeasureTime frame
quadriceps muscle function12weeks

Secondary

MeasureTime frame
ASM(appendicular skeletal mass) marker12weeks
Short Physical Performance Battery, SPPB12weeks

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026